PHC4 COST-EFFECTIVENESS OF PIMOBENDAN VERSUS BENAZEPRIL IN ACQUIRED MYXOMATOUS MITRAL VALVE DISEASE IN DOGS- AN ADAPTATION TO SWITZERLAND
May 1, 2009, 00:00
10.1016/S1098-3015(10)73372-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)73372-6/fulltext
Title :
PHC4 COST-EFFECTIVENESS OF PIMOBENDAN VERSUS BENAZEPRIL IN ACQUIRED MYXOMATOUS MITRAL VALVE DISEASE IN DOGS- AN ADAPTATION TO SWITZERLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73372-6&doi=10.1016/S1098-3015(10)73372-6
First page :
Section Title :
Open access? :
No
Section Order :
805